Boston Scientific Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $966.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $88.0M | 9.1% |
| Business Acquisitions | $64.4M | 6.7% |
| Other Financing | $168.6M | 17.5% |
| Working Capital | $641.0M | 66.4% |
| Other | $4.0M | 0.4% |
| Net Cash Flow | $0 | 0.0% |